COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?

Ho, Wei Shen; Zhang, Ruirui; Tan, Yeong Lan; Chai, Christina Li Lin

Ho, Wei Shen; Zhang, Ruirui; Tan, Yeong Lan; Chai, Christina Li Lin.

Afiliação

Ho WS; Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore.
Zhang R; Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore.
Tan YL; Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore.
Chai CLL; Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore. Electronic address: phacllc@nus.edu.sg.

Pharmacol Res ; 179: 106201, 2022 05.

Article em En | MEDLINE | ID: mdl-35367622

Assuntos

Tratamento Farmacológico da COVID-19; Antivirais/uso terapêutico; Humanos; Pandemias; Estudos Retrospectivos; SARS-CoV-2

Palavras-chave

Antivirals; Baricitinib (PubChem CID: 44205240); COVID-19; Chloroquine (PubChem CID: 2719); Dexamethasone (PubChem CID: 5743); Drug discovery; Hydroxychloroquine (PubChem CID: 3652); Ivermectin (PubChem CID: 6321424); Lopinavir (PubChem CID: 92727); Molnupiravir (Pubchem CID: 145996610); Nirmatrelvir (PubChem CID: 155903259); Remdesivir (PubChem CID: 121304016); Ritonavir (PubChem CID: 392622); Small molecule therapeutics

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google